Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [1] The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis
    Kucukceran, Kadir
    Ergin, Mehmet
    Kilinc, Ibrahim
    Karaibrahimoglu, Adnan
    Colak, Tamer
    Tuncar, Alpay
    Dundar, Zerrin Defne
    Kocak, Sedat
    Girisgin, Abdullah Sadik
    Gul, Mehmet
    Cander, Basar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (06) : 1175 - 1181
  • [2] Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism
    Oblitas, Crhistian-Mario
    Lopez-Rubio, Marina
    Lago-Rodriguez, Marta-Olimpia
    Galeano-Valle, Francisco
    Garcia-Gamiz, Mercedes
    Zamora-Trillo, Angielys
    Walther, Luis-Antonio Alvarez-Sala
    Demelo-Rodriguez, Pablo
    MEDICINA CLINICA, 2024, 163 (06): : 281 - 285
  • [3] Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
    Hoybye, Charlotte
    Faseh, Laia
    Himonakos, Christos
    Pielak, Tomasz
    Eugen-Olsen, Jesper
    ENDOCRINE CONNECTIONS, 2019, 8 (06): : 772 - 779
  • [4] The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection
    Aslan, Sevinc
    Demirdal, Tuna
    Erbak, Huriye
    Aslan, Cem
    INFECTIOUS DISEASES, 2020, 52 (02) : 107 - 113
  • [5] Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
    Lippi, Giuseppe
    Henry, Brandon M.
    Favaloro, Emmanuel J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (11) : E413 - E415
  • [6] Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure
    Koch, Alexander
    Zimmermann, Henning W.
    Gassler, Nikolaus
    Jochum, Christoph
    Weiskirchen, Ralf
    Bruensing, Jan
    Buendgens, Lukas
    Dueckers, Hanna
    Bruns, Tony
    Gerken, Guido
    Neumann, Ulf P.
    Adams, David H.
    Trautwein, Christian
    Canbay, Ali
    Tacke, Frank
    LIVER INTERNATIONAL, 2014, 34 (09) : 1330 - 1339
  • [7] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    JOINT BONE SPINE, 2013, 80 (01) : 96 - 98
  • [8] Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
    Toldi, Gergely
    Biro, Edina
    Szalay, Balazs
    Stenczer, Balazs
    Molvarec, Attila
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Beko, Gabriella
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) : 1873 - 1876
  • [9] Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals
    Chew-Harris, Janice
    Appleby, Sarah
    Richards, A. Mark
    Troughton, Richard W.
    Pemberton, Christopher J.
    CLINICAL BIOCHEMISTRY, 2019, 69 : 36 - 44
  • [10] Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis
    Georgescu, Anca-Meda
    Szederjesi, Janos
    Voidazan, Septimiu
    Dobreanu, Minodora
    Copotoiu, Sanda Maria
    Hutanu, Adina
    Azamfirei, Leonard
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2015, 23 (01): : 59 - 73